Bibaswan Lahiri

Bibaswan Lahiri

Risk Transformation Analyst @ KPMG India

About Bibaswan Lahiri

Bibaswan Lahiri is a Risk Transformation Analyst at KPMG India, focusing on innovative solutions in the intersection of health science and risk management. He holds a Bachelor's in Pharmacy and a Master's in Drug Regulatory Affairs from Acharya Institutes.

Work at KPMG India

Bibaswan Lahiri currently holds the position of Risk Transformation Analyst at KPMG India. His role involves engaging with the risk transformation sector, focusing on innovative solutions to complex problems. Based in Bengaluru, Karnataka, he contributes to projects that explore the intersection of health science and risk management, leveraging his educational background and professional experience.

Education and Expertise

Bibaswan Lahiri completed his Bachelor of Pharmacy (BPharm) at Acharya Institutes from 2015 to 2019. He further pursued a Master's in Drug Regulatory Affairs at the same institution, studying from 2019 to 2021. His educational background equips him with knowledge in pharmacy administration, policy, and regulatory affairs, which supports his current role in risk transformation.

Background

Bibaswan Lahiri is based in Bangalore Urban, India. He has a diverse professional background that includes experience in regulatory affairs and industrial training. Prior to his current position at KPMG, he worked as a Regulatory Affairs Associate at La Machinotech for six months in 2020 and completed industrial training at Albert David Limited in 2019.

Achievements

Bibaswan Lahiri has developed expertise in risk transformation and regulatory affairs through his education and work experience. His involvement in the health science sector and risk management reflects his commitment to finding innovative solutions to complex challenges. His educational qualifications and professional roles demonstrate his capability in navigating the regulatory landscape within the pharmaceutical and risk management fields.

People similar to Bibaswan Lahiri